Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/08/22 07:00:40 on US and Canada Markets.
MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) today announced revisions to its SailSAFE health and safety protocols which further align the Company to the broader travel, leisure and hospitality industry worldwide. Va...
Black Wolf Nation Partners with Push The Envelope PR PR Newswire Men's skin & hair-care brand, Black Wolf Nation has doubled its strategic business efforts by joining forces with Push The Envelope PR. WEST PALM BEACH, Fla. , Aug. 8, 2022 /PRNe...
LSB Industries, Inc. (“LSB” or “the Company”), (NYSE: LXU), today announced that its Board of Directors has authorized an increase in the size of the Company’s previously announced $50 million stock repurchase program implemented in May 2022. Under the...
KKR, a leading global investment firm, today announced that KKR has sold a portfolio of distribution properties located in Chicago to a global investment manager. The portfolio consists of 13 assets with approximately 1.7 million square feet (SF) of warehouse space and average clear hei...
Whirlpool Corporation Announces Acquisition of InSinkErator PR Newswire BENTON HARBOR, Mich. , Aug. 8, 2022 /PRNewswire/ -- Whirlpool Corporation (NYSE: WHR) today announced that it has entered into a definitive agreement with Emerson Electric Co. (NYSE: ...
Digital Realty Announces Non-Core Disposition PR Newswire Recycles capital from mature asset in U.S. to reinvest in growing, global platform AUSTIN, Texas , Aug. 8, 2022 /PRNewswire/ -- Digital Realty (NYSE: DLR), the largest global provider ...
CIBC TO ENHANCE SECURE AND SEAMLESS ACCESS TO FINANCIAL TOOLS AND APPS FOR CLIENTS THROUGH AGREEMENT WITH MX Canada NewsWire TORONTO , Aug. 8, 2022 /CNW/ - Today CIBC (TSX: CM) (NYSE: CM) announced a data access agreement with MX to enhance the ...
MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop resistance to targeted therapy Global SAFFRON Phase III trial evaluating this combination is underway Preliminary results from the SAVANNAH Phase II trial showed that T...
– Initiated a Phase 1 trial of VGL101 in healthy volunteers in Australia – – Received U.S. FDA orphan drug designation for VGL101 for the treatment of patients with ALSP – – Prioritizing VGL101 in ALSP and small molecule TREM2 agonist...
Successfully met the primary endpoint in the BrigHtn trial, delivering a 20.3 mmHg reduction in systolic blood pressure (SBP), or an 11 mmHg (p-value < 0.0001) decline on a placebo-adjusted basis, at 2 mg dose Independent Data Review Committee determined that the trial met pr...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
8.43%Change Percent:
Toyota Motor Corp Company Name:
TOYOF Stock Symbol:
OTCMKTS Market:
global.toyota Website: